Literature DB >> 28099709

Preliminary study of the effects of furosemide on blood pressure during late-onset pre-eclampsia in patients with high cardiac output.

Péter Tamás1,2, Eszter Hantosi1,2, Bálint Farkas2,3, Zsolt Ifi1,2, József Betlehem1, József Bódis1,2,3.   

Abstract

OBJECTIVE: To examine the effect of furosemide on hypertension and edema in patients with pre-eclampsia experiencing high cardiac output.
METHODS: The present cohort study enrolled patients with pre-eclampsia who were admitted to the pregnancy pathology unit of the Department of Obstetrics and Gynecology, University of Pécs, Hungary, between January 1 and December 31, 2015. Eligible patients had singleton pregnancies with no fetal anomalies, high blood volume, visible edema, and a hematocrit concentration below 37 L/L. Blood pressure was measured and impedance cardiography was used to determine cardiac output for all patients before they received a 40-mg dose of furosemide; after 60 minutes blood pressure and cardiac output were measured again.
RESULTS: The study enrolled 14 patients. Lower cardiac output (P=0.002), systolic blood pressure (P=0.002), and diastolic blood pressure (P=0.002) were recorded after furosemide administration, with patient heart rates remaining stable.
CONCLUSION: The heart-rate stability suggests that the change of cardiac output was due to a decrease in blood volume. These data suggest that diuretics could be useful in the management of late-onset pre-eclampsia, indicating that an increase in water retention could play a role in the development of late-onset pre-eclampsia.
© 2016 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Furosemide; High cardiac output; Late-onset pre-eclampsia; Management

Mesh:

Substances:

Year:  2016        PMID: 28099709     DOI: 10.1002/ijgo.12019

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

1.  Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.

Authors:  Szilvia Szabo; Katalin Karaszi; Roberto Romero; Eszter Toth; Andras Szilagyi; Zsolt Gelencser; Yi Xu; Andrea Balogh; Gabor Szalai; Petronella Hupuczi; Beata Hargitai; Tibor Krenacs; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Katalin A Kekesi; Adi L Tarca; Offer Erez; Gabor Juhasz; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  Placenta       Date:  2020-06-22       Impact factor: 3.481

2.  Identifying key genes and drug screening for preeclampsia based on gene expression profiles.

Authors:  Zhengfang Xu; Chengjiang Wu; Yanqiu Liu; Nian Wang; Shujun Gao; Shali Qiu; Zhutao Wang; Jing Ding; Lubin Zhang; Hui Wang; Weijiang Wu; Bing Wan; Jun Yu; Jie Fang; Peifang Yang; Qixiang Shao
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 3.  Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications.

Authors:  Wilfried Gyselaers
Journal:  J Clin Med       Date:  2019-03-11       Impact factor: 4.241

Review 4.  High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice.

Authors:  Diane Xavier de Ávila; Humberto Villacorta; Wolney de Andrade Martins; Evandro Tinoco Mesquita
Journal:  Curr Cardiol Rev       Date:  2022

5.  Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Wen-Fei Zheng; Jingqiong Zhan; Aihua Chen; Huigai Ma; Huaijie Yang; Rashmisha Maharjan
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.